Company intelligence / Profile preview

Puresyn

Malvern, Pennsylvania, United Statespuresyn.com ↗

Ownership: Private
Development stage: Commercial

Overview

Puresyn provides commercial-scale cGMP-grade plasmid DNA manufacturing services using proprietary purification technologies. Its products have been used in clinical studies including phase 1 and registration trials by client companies developing gene and cell therapies. The company has received NIH funding to develop scalable nucleic acid purification processes and has supported FDA-approved cGMP studies with its vectors[1][2].

Modalities: Plasmid DNA (Biologic)Gene therapy enabling materials (Biologic)Viral vector enabling materials (Biologic)
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Puresyn.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Puresyn.

Explore the full profile